CEP-37440

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C30H38ClN7O3
Molecular Weight	580.121
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CNC(=O)C1=CC=CC=C1NC2=NC(NC3=C(OC)C4=C(C[C@H](CCC4)N5CCN(CCO)CC5)C=C3)=NC=C2Cl

InChI

InChIKey=BCSHRERPHLTPEE-NRFANRHFSA-N

InChI=1S/C30H38ClN7O3/c1-32-29(40)23-7-3-4-9-25(23)34-28-24(31)19-33-30(36-28)35-26-11-10-20-18-21(6-5-8-22(20)27(26)41-2)38-14-12-37(13-15-38)16-17-39/h3-4,7,9-11,19,21,39H,5-6,8,12-18H2,1-2H3,(H,32,40)(H2,33,34,35,36)/t21-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C30H38ClN7O3
Molecular Weight	580.121
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27527804
Curator's Comment: Description was created based on several sources, including: https://www.ncbi.nlm.nih.gov/pubmed/27009091 | https://www.ncbi.nlm.nih.gov/pubmed/26753004

CEP-37440 is a potent ATP-competitive, highly kinase selective, and orally active inhibitor of FAK1 and anaplastic lymphoma kinase (ALK). In addition to a favorable metabolic stability and pharmacokinetic profile preclinically, CEP-37440 is also a brain penetrant. CEP-37440 was able to inhibit the proliferation of certain IBC cells by decreasing the levels of phospho-FAK1 (Tyr 397); none of the cells expressed ALK. Studies using IBC xenograft models showed that CEP-37440 also effectively reduces the growth of the primary tumor xenografts and inhibits the development of brain metastases in mice.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Focal adhesion kinase 1 13 Target ID: CHEMBL2695 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27527804	Inhibitor 8504		2.0 nM [IC50]
ALK tyrosine kinase receptor 24 Target ID: CHEMBL4247 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27527804 \| https://www.ncbi.nlm.nih.gov/pubmed/27009091	Inhibitor 8504		3.1 nM [IC50]

Conditions

Condition	Modality	Targets	Highest Phase	Product
Solid tumors 147 Sources: https://clinicaltrials.gov/ct2/show/NCT01922752	Primary		Phase I 438	Unknown Approved Use Unknown

C_max

Value	Dose	Co-administered	Analyte	Population
1533 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/27527804	10 mg/kg single, oral dose: 10 mg/kg route of administration: Oral experiment type: SINGLE co-administered:		CEP-37440 plasma	Mus musculus population: UNKNOWN age: ADULT sex: UNKNOWN food status: UNKNOWN

AUC

Value	Dose	Co-administered	Analyte	Population
1612 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/27527804	1 mg/kg single, intravenous dose: 1 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered:		CEP-37440 plasma	Mus musculus population: UNKNOWN age: ADULT sex: UNKNOWN food status: UNKNOWN
16429 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/27527804	10 mg/kg single, oral dose: 10 mg/kg route of administration: Oral experiment type: SINGLE co-administered:		CEP-37440 plasma	Mus musculus population: UNKNOWN age: ADULT sex: UNKNOWN food status: UNKNOWN

T_1/2

Value	Dose	Co-administered	Analyte	Population
3 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/27527804	1 mg/kg single, intravenous dose: 1 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered:		CEP-37440 plasma	Mus musculus population: UNKNOWN age: ADULT sex: UNKNOWN food status: UNKNOWN

Sourcing

Vendor/Aggregator	ID	URL
1PlusChem LLC	1P009CR5	https://www.1pchem.com/search?query=1P009CR5
ApexBio Technology	B3271	https://www.apexbt.com/catalogsearch/result/?q=B3271
AstaTech	F13321	http://astatechinc.com/CPSResult.php?CRNO=F13321
Cayman Chemical	21278	http://www.caymanchem.com/app/template/Product.vm/catalog/21278
Chem Scene	CS-2684	http://www.chemscene.com/goproductList/searchProductList?productObj=CS-2684
ChemShuttle	157280	https://www.chemshuttle.com/catalogsearch/result/?q=157280
Combi-Blocks	QV-7347	http://www.combi-blocks.com/cgi-bin/find.cgi?QV-7347
eMolecules	108759164	https://orderbb.emolecules.com/search/#?query=108759164
eMolecules	301191637	https://orderbb.emolecules.com/search/#?query=301191637
eMolecules	50282356	https://orderbb.emolecules.com/search/#?query=50282356
Excenen	EX-A1543	http://www.excenen.com/searchresultlist.php?id=EX-A1543
Excenen	EX-A1625	http://www.excenen.com/searchresultlist.php?id=EX-A1625
mcule	MCULE-3401000639	https://mcule.com/MCULE-3401000639/
mcule	MCULE-8370728429	https://mcule.com/MCULE-8370728429/
MedChem Express	HY-15841	https://www.medchemexpress.com/search.html?q=HY-15841&ft=&fa=&fp=
Molnova	M17273	https://www.molnova.com/en/serch-list.html?keywords=M17273
MolPort	MolPort-042-676-269	https://www.molport.com/shop/molecule-link/MolPort-042-676-269
MolPort	MolPort-044-561-845	https://www.molport.com/shop/molecule-link/MolPort-044-561-845
MuseChem	I001499	https://www.musechem.com/product/I001499.html
TargetMol	T2655	https://www.targetmol.com/search?keyword=T2655

PubMed

Title	Date	PubMed
Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK).	2016-08-25	27527804
ALK inhibitors in non-small cell lung cancer: crizotinib and beyond.	2014-07	25322323

Patents

Sample Use Guides

In Vivo Use Guide

CEP-37440 supplied as 25 mg and 100 mg capsules and orally administered daily.

Route of Administration: Oral

In Vitro Use Guide

CEP-37440 was screened against both NPM-ALK+ ALCL cell lines (Sup-M2 and Karpas-299) and NPM-ALK− hematologic cell lines (Hut-102 and K562) and demonstrated selective cytotoxicity in the oncogene-addicted cell lines in nanomolar range

Substance Class	Chemical Created by `admin` on `Mon Mar 31 21:33:33 GMT 2025` Edited by `admin` on `Mon Mar 31 21:33:33 GMT 2025`
Record UNII	O3MNS8782H
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ALK-FAK INHIBITOR CEP-37440

Preferred Name

English

CEP-37440

Common Name

English

BENZAMIDE, 2-((5-CHLORO-2-(((6S)-6,7,8,9-TETRAHYDRO-6-(4-(2-HYDROXYETHYL)-1-PIPERAZINYL)-1-METHOXY-5H-BENZOCYCLOHEPTEN-2-YL)AMINO)-4-PYRIMIDINYL)AMINO)-N-METHYL-

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C129825